Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30982686

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2019 May 11
First author
Al-Batran SE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 May 11;393(10184):1914-1916. doi: 10.1016/S0140-6736(18)33189-1.
    note
    Source null
    related pmid
    30982685
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Aug;16(8):465. doi: 10.1038/s41571-019-0215-3.
    note
    Source null
    related pmid
    31019282
    relationship
    Comment in
  3. citation
    Lancet. 2020 Jan 11;395(10218):e2. doi: 10.1016/S0140-6736(19)32505-X.
    note
    Source null
    related pmid
    31929020
    relationship
    Comment in
  4. citation
    Lancet. 2020 Jan 11;395(10218):e3. doi: 10.1016/S0140-6736(19)32509-7.
    note
    Source null
    related pmid
    31929021
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2019 Dec;11(12):5694-5700. doi: 10.21037/jtd.2019.12.103.
    note
    Source null
    related pmid
    32030305
    relationship
    Comment in
  6. citation
    Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):653-662. doi: 10.1016/j.ijrobp.2019.12.011.
    note
    Source null
    related pmid
    32092335
    relationship
    Comment in

Authors and identifiers

  1. name
    Al-Batran SE
    type
    Author
  2. name
    Homann N
    type
    Author
  3. name
    Pauligk C
    type
    Author
  4. name
    Goetze TO
    type
    Author
  5. name
    Meiler J
    type
    Author
  6. name
    Kasper S
    type
    Author
  7. name
    Kopp HG
    type
    Author
  8. name
    Mayer F
    type
    Author
  9. name
    Haag GM
    type
    Author
  10. name
    Luley K
    type
    Author
  11. name
    Lindig U
    type
    Author
  12. name
    Schmiegel W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Al-Batran SE
    type
    Author
  2. name
    Homann N
    type
    Author
  3. name
    Pauligk C
    type
    Author
  4. name
    Goetze TO
    type
    Author
  5. name
    Meiler J
    type
    Author
  6. name
    Kasper S
    type
    Author
  7. name
    Kopp HG
    type
    Author
  8. name
    Mayer F
    type
    Author
  9. name
    Haag GM
    type
    Author
  10. name
    Luley K
    type
    Author
  11. name
    Lindig U
    type
    Author
  12. name
    Schmiegel W
    type
    Author
bibliography ids
  1. nci-bib-a5cbc4378b60e3e8df52488d
book metadata
content sha256
6fbe1a34cdbccf29bb89503c1a48cb2f09be635dea652e2dd0d0e43d95d468a6
document type
citation
dois
  1. 10.1016/S0140-6736(18)32557-1
electronic publication date
display
2019 Apr 11
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30982686
immutable id
pubmed:30982686@6fbe1a34cdbccf29bb89503c1a48cb2f09be635dea652e2dd0d0e43d95d468a6
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10184
name
Lancet (London, England)
nlm unique id
2985213R
pages
1948-1957
volume
393
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 May 11;393(10184):1914-1916. doi: 10.1016/S0140-6736(18)33189-1.
    note
    Source null
    related pmid
    30982685
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Aug;16(8):465. doi: 10.1038/s41571-019-0215-3.
    note
    Source null
    related pmid
    31019282
    relationship
    Comment in
  3. citation
    Lancet. 2020 Jan 11;395(10218):e2. doi: 10.1016/S0140-6736(19)32505-X.
    note
    Source null
    related pmid
    31929020
    relationship
    Comment in
  4. citation
    Lancet. 2020 Jan 11;395(10218):e3. doi: 10.1016/S0140-6736(19)32509-7.
    note
    Source null
    related pmid
    31929021
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2019 Dec;11(12):5694-5700. doi: 10.21037/jtd.2019.12.103.
    note
    Source null
    related pmid
    32030305
    relationship
    Comment in
  6. citation
    Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):653-662. doi: 10.1016/j.ijrobp.2019.12.011.
    note
    Source null
    related pmid
    32092335
    relationship
    Comment in
outcomes validated
false
pmid
30982686
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
a157b9423682e2a6e9b6204adc2f4ac536464a73060c46a2e1e76780e9808e24
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 May 11
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30982686/
title
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Preserved source evidence · Not medical advice